SA medtech company AI Diagnostics raises R85 million to accelerate AI-powered TB screening
A South African medtech company has secured R85 million in funding to advance the use of its proprietary hardware and AI software in combatting the tuberculosis (TB) epidemic. The affordable solution, praised by investors for its social impact and innovation, makes TB screening easy and accessible for frontline health workers.
One Africa, one cure: Making CAR-T Cell therapy accessible across Africa
CAR-T cell therapy is a form of personalised medicine in which a person’s own immune cells are collected and modified in a specialised laboratory so they can better recognise and attack certain blood cancers. It is used in some countries for patients with specific types of lymphoma and leukaemia when other treatments have not worked. It is only available in a few highly specialised hospitals around the world.
Rare Disease Day 2026 puts equity for patients in the spotlight
Rare diseases each affect relatively small numbers of people, but collectively they impact more than 300 million individuals worldwide across over 7,000 known conditions, with 70% of these starting in childhood.1 For many patients and families, the reality is often long diagnostic journeys, uncertainty and ongoing challenges in accessing treatment and support.
Sanofi receives registration for Beyfortus® in South Africa to protect infants against RSV
Sanofi is pleased to share that the South African Health Products Regulatory Authority (SAHPRA) has granted registration for Beyfortus® (nirsevimab), a long-acting monoclonal antibody designed to protect infants against Respiratory Syncytial Virus (RSV).
Cipla partners with ImmunoACT to launch talicabtagene autoleucel, an anti-CD19 CAR-T cell therapy for blood cancers in Africa
Cipla Limited (BSE: 500087; NSE: CIPLA; and hereafter referred to as “Cipla”), through its subsidiary Medpro Pharmaceutica, has entered into an exclusive license and supply agreement with Immunoadoptive Cell Therapy Private Limited (ImmunoACT). Under this partnership, Cipla will commercialize talicabtagene autoleucel, India’s first indigenously developed CAR-T cell therapy, in the Republic of South Africa, Algeria, and Morocco.
The mouth–body connection: Why diabetes and oral health go hand in hand
Every November, National Diabetes Month invites South Africans to take a closer look at one of the country’s most urgent health concerns, and one that’s still growing rapidly. But beyond blood sugar and diet, there’s another piece of the puzzle that often goes unnoticed: the link between oral health and diabetes
Aspen highlights the rising diabetes disease burden
On World Diabetes Day, JSE-listed Aspen Pharmacare Holdings Limited (“Aspen”), a global multinational specialty pharmaceutical company, continues to highlight the alarming impact of South Africa’s increasing type 2 diabetes burden.
Bonitas and partners drive family health access at Mpumalanga Family Health Day
Access to healthcare is one of South Africa’s most pressing public health challenges, with many families still facing barriers such as long travel distances, overburdened clinics and limited screening opportunities. These realities mean preventable or manageable conditions often go undetected until they become serious.
SURGEONS FOR LITTLE LIVES
A decade of hope and healing: Surgeons for Little Lives marks 10 years of transforming paediatric care
Every day for ten years, Surgeons for Little Lives has stood beside children and families, providing life-saving care and support.
SA’s sugar habits in the spotlight as new guide reveals hidden sugar traps and how to avoid them
Sugar is silently fuelling a national health crisis and most South Africans don’t even know it. With daily sugar intake far exceeding safe limits, Pharma Dynamics and the Heart Stroke Foundation SA (HSFSA) have launched a practical, easy-to-follow guide to help the public spot hidden sugars, make smarter food choices and protect their heart health.
Meet the latest viral sensation – Flumune C
Meet the latest viral sensation – Flumune C If you’ve ever stared at the endless wall of effervescents at any pharmacy, desperately Googling “best immune booster for adults” only to come out more confused, you’re not alone. Once a simple place, the immune booster...
The true burden of eczema goes beyond the itch
World Atopic Eczema Day 2025 calls for early intervention, better care, and greater awareness of the hidden toll of atopic dermatitis.
Boehringer Ingelheim and Aspen Pharmacare Announce New Partnership to Bring Treatments Closer to Patients in South Africa
As of September 2025, Aspen Pharmacare will undertake the distribution of selected Boehringer Ingelheim prescription medicines across South Africa. This partnership represents a significant step towards ensuring that more patients gain timely access to the treatments they need, helping improve health outcomes today and for generations to come.
A vaccine wake-up call for South Africa
Time to work together to close vaccine gap putting children and communities at risk
